Axitinib after Sunitinib in Metastatic Renal Cancer: Preliminary Results from Italian "Real-World" SAX Study.
about
Axitinib in metastatic renal cell carcinoma: beyond the second-line setting.Axitinib in metastatic renal cell carcinoma: patient characteristics and treatment patterns in US community oncology centers.Axitinib in the treatment of renal cell carcinoma: design, development, and place in therapy.Network meta-analysis of second-line treatment in metastatic renal cell carcinoma: efficacy and safety.
P2860
Axitinib after Sunitinib in Metastatic Renal Cancer: Preliminary Results from Italian "Real-World" SAX Study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Axitinib after Sunitinib in Me ...... talian "Real-World" SAX Study.
@en
Axitinib after Sunitinib in Me ...... talian "Real-World" SAX Study.
@nl
type
label
Axitinib after Sunitinib in Me ...... talian "Real-World" SAX Study.
@en
Axitinib after Sunitinib in Me ...... talian "Real-World" SAX Study.
@nl
prefLabel
Axitinib after Sunitinib in Me ...... talian "Real-World" SAX Study.
@en
Axitinib after Sunitinib in Me ...... talian "Real-World" SAX Study.
@nl
P2093
P2860
P50
P356
P1476
Axitinib after Sunitinib in Me ...... Italian "Real-World" SAX Study
@en
P2093
Azzurra Farnesi
Carmine D'Aniello
Emanuele Naglieri
Ferdinando De Vita
Francesco Grillone
Giacomo Cartenì
Giuseppe Quarto
Lorenzo Calvetti
Luca Galli
Maria G Vitale
P2860
P356
10.3389/FPHAR.2016.00331
P50
P577
2016-09-28T00:00:00Z